Laronidase Completed Phase 2 Trials for Mucopolysaccharidosis V / Type 1 Mucopolysaccharidosis / Hurler-Scheie Syndrome / Hurlers Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00146757A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old